Theralink Technologies Inc (THER)

[penny_hunter_]

I received email from Andrew Kucharchuk today and things are going as planned with phase 2 trial.

“we know the process is ongoing and are optimistic we will get the requisite green lights soon. As we recently disclosed, we are also in negotiations to initiate a second phase 2 study of ProscaVax in the U.S. with UCNT, which we are very excited about given the eagerness of the organization to conduct a trial that they believe has the potential to be beneficial to so many of their patients.”